Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:organ lesion measurement
go back to main search page
Accession:CMO:0000677 term browser browse the term
Definition:Measurement of a lesion in an organ. A lesion is a localized pathological change in structure of an organ or tissue due to injury or disease; especially one that is circumscribed and well defined.
Synonyms:related_synonym: tissue damage measurement


show annotations for term's descendants           Sort by:
 
organ lesion measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Klgr1 Kidney lesion grade QTL 1 IDA RGD PMID:16534143 RGD:1578520 NCBI chr 8:33,558,660...109,028,082 JBrowse link
Q Rends2 Renal damage susceptibility QTL 2 IDA renal vascular damage RGD PMID:12874092 RGD:631854 NCBI chr 1:20,341,560...58,000,154 JBrowse link
Q Rends3 Renal damage susceptibility QTL 3 IDA renal vascular damage RGD PMID:12874092 RGD:631854 NCBI chr10:82,675,233...88,141,097 JBrowse link
Q Rends4 Renal damage susceptibility QTL 4 IDA renal vascular damage RGD PMID:12874092 RGD:631854 NCBI chr16:1...27,556,253 JBrowse link
area of individual liver tumorous lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar6 Hepatocarcinoma resistance QTL 6 IDA RGD PMID:10850431 RGD:619609
area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Prcr1 Prostate cancer resistance QTL 1 IDA RGD PMID:15805257 RGD:1358944 NCBI chr 2:93,995,316...169,852,800 JBrowse link
Q Prcr2 Prostate cancer resistance QTL 2 IDA RGD PMID:15805257 RGD:1358944 NCBI chr 1:21,812,623...44,409,802 JBrowse link
brain infarction volume term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Bp49 Blood pressure QTL 49 IDA RGD PMID:9241273 RGD:61056 NCBI chr 5:61,612,600...102,331,727 JBrowse link
index of glomerular damage term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Glom10 Glomerulus QTL 10 IDA RGD PMID:16720678 RGD:1581737 NCBI chr11:1...33,867,429 JBrowse link
Q Glom11 Glomerulus QTL 11 IDA RGD PMID:16720678 RGD:1581737
Q Glom12 Glomerulus QTL 12 IDA RGD PMID:16720678 RGD:1581737 NCBI chr 5:34,402,409...79,402,409 JBrowse link
Q Glom13 Glomerulus QTL 13 IDA RGD PMID:16720678 RGD:1581737
Q Glom14 Glomerulus QTL 14 IDA RGD PMID:16720678 RGD:1581737 NCBI chr15:41,068,094...86,068,094 JBrowse link
Q Glom17 Glomerulus QTL 17 IDA RGD PMID:18682577 RGD:2312422 NCBI chr 1:177,235,071...208,786,962 JBrowse link
Q Glom18 Glomerulus QTL 18 IDA RGD PMID:18682577 RGD:2312422 NCBI chr 1:201,358,068...252,480,016 JBrowse link
Q Glom19 Glomerulus QTL 19 IDA RGD PMID:18682577 RGD:2312422 NCBI chr 4:49,906,054...145,611,886 JBrowse link
Q Glom20 Glomerulus QTL 20 IDA RGD PMID:18682577 RGD:2312422 NCBI chr11:46,583,209...86,714,631 JBrowse link
Q Glom21 Glomerulus QTL 21 IDA RGD PMID:18682577 RGD:2312422 NCBI chr18:5,430,134...41,781,619 JBrowse link
Q Glom9 Glomerulus QTL 9 IDA RGD PMID:16720678 RGD:1581737 NCBI chr 2:95,946,719...140,946,719 JBrowse link
Q Rends1 Renal damage susceptibility QTL 1 IDA RGD PMID:10454439 RGD:632218 NCBI chr 1:137,787,261...236,763,528 JBrowse link
Q Rf57 Renal function QTL 57 IDA RGD PMID:19584172 RGD:2316856 NCBI chr 5:61,086,653...93,273,130 JBrowse link
Q Rf58 Renal function QTL 58 IDA RGD PMID:19584172 RGD:2316856 NCBI chr 7:55,072,862...123,602,998 JBrowse link
Q Rf9 Renal function QTL 9 IDA RGD PMID:14532335 RGD:727992 NCBI chr 2:138,901,276...217,498,710 JBrowse link
kidney crescentic glomeruli count to kidney normal glomeruli count ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Glom27 Glomerulus QTL 27 IDA RGD PMID:22445570 RGD:7207870 NCBI chr13:24,502,279...108,770,533 JBrowse link
kidney sclerotic glomeruli count to total glomeruli count ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Glom15 Glomerulus QTL 15 IDA RGD PMID:16482158 RGD:2293335 NCBI chr13:80,403,559...108,770,687 JBrowse link
Q Glom16 Glomerulus QTL 16 IDA RGD PMID:16482158 RGD:2293335 NCBI chr16:1,550,187...49,247,447 JBrowse link
Q Glom24 Glomerulus QTL 24 IDA RGD PMID:16482158 RGD:2293335 NCBI chr 5:101,265,591...141,912,026 JBrowse link
liver nonremodeling tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA RGD PMID:15185337 RGD:737884 NCBI chr18:53,033,494...87,080,053 JBrowse link
liver nonremodeling tumorous lesion volume to total liver volume ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar13 Hepatocarcinoma resistance QTL 13 IDA RGD PMID:15185337 RGD:737884 NCBI chr 4:1...31,554,484 JBrowse link
Q Hcas6 Hepatocarcinoma susceptibility QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr14:61,873,323...88,870,994 JBrowse link
Q Hcas7 Hepatocarcinoma susceptibility QTL 7 IDA RGD PMID:15185337 RGD:737884 NCBI chr15:2,327,877...53,535,766 JBrowse link
liver remodeling tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA RGD PMID:15185337 RGD:737884 NCBI chr 2:1...41,179,397 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:1...47,622,148 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:65,008,245...91,629,354 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:80,403,559...91,629,354 JBrowse link
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA RGD PMID:12672032 RGD:629574 NCBI chr 7:40,872,682...85,872,682 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA RGD PMID:12672032 RGD:629574 NCBI chr 1:255,728,828...282,763,074 JBrowse link
liver tumorous lesion area to total liver area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:71,476,518...116,476,518 JBrowse link
Q Hcar8 Hepatocarcinoma resistance QTL 8 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:123,478,354...168,478,354 JBrowse link
liver tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA RGD PMID:12154055 RGD:629566 NCBI chr 8:44,219,197...89,542,960 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA RGD PMID:12154055 RGD:629566 NCBI chr 6:86,422,697...115,379,601 JBrowse link
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA RGD PMID:15771619 RGD:1358145 NCBI chr 1:163,796,316...282,763,074 JBrowse link
Q Hcar5 Hepatocarcinoma resistance QTL 5 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:236,763,415...247,065,599 JBrowse link
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:71,476,518...116,476,518 JBrowse link
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 1:5,655,769...122,614,963 JBrowse link
Q Hcas5 Hepatocarcinoma susceptibility QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr 1:191,825,895...279,986,079 JBrowse link
Q Hcas8 Hepatocarcinoma susceptibility QTL 8 IDA RGD PMID:17079458 RGD:1599590 NCBI chr16:1...24,228,366 JBrowse link
liver tumorous lesion number to liver area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar4 Hepatocarcinoma resistance QTL 4 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:210,960,636...236,763,528 JBrowse link
liver tumorous lesion volume to total liver volume ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcas1 Hepatocarcinoma susceptibility QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr 7:100,160,423...140,335,001 JBrowse link
Q Hcas3 Hepatocarcinoma susceptibility QTL 3 IDA RGD PMID:12154055 RGD:629566 NCBI chr 1:156,446,196...243,311,614 JBrowse link
mammary tumor growth rate term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mamtr7 Mammary tumor resistance QTL 7 IDA RGD PMID:19052818 RGD:2302423 NCBI chr10:9,841,807...108,540,162 JBrowse link
Q Mamtr8 Mammary tumor resistance QTL 8 IDA RGD PMID:19052818 RGD:2302423 NCBI chr18:32,670,352...87,080,053 JBrowse link
Q Mcs20 Mammary carcinoma susceptibility QTL 20 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 9:15,554,901...47,249,201 JBrowse link
Q Mcs21 Mammary carcinoma susceptibility QTL 21 IDA RGD PMID:16596452 RGD:1599317 NCBI chr10:30,021,354...54,057,745 JBrowse link
Q Mcs22 Mammary carcinoma susceptibility QTL 22 IDA RGD PMID:16596452 RGD:1599317 NCBI chr18:54,108,375...68,819,562 JBrowse link
mammary tumor incidence/prevalence measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mcs31 Mammary carcinoma susceptibility QTL 31 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 9:90,024,661...119,983,851 JBrowse link
Q Mcs32 Mammary carcinoma susceptibility QTL 32 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 1:122,614,824...262,664,716 JBrowse link
Q Mcs33 Mammary carcinoma susceptibility QTL 33 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 5:136,640,731...173,707,219 JBrowse link
Q Mcs34 Mammary carcinoma susceptibility QTL 34 IDA RGD PMID:23967281 RGD:7794780
mammary tumor number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca11 Estrogen-induced mammary cancer QTL 11 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:103,580,245...117,037,276 JBrowse link
Q Emca12 Estrogen-induced mammary cancer QTL 12 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:129,038,716...139,099,229 JBrowse link
Q Emca13 Estrogen-induced mammary cancer QTL 13 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:9,514,842...103,580,403 JBrowse link
Q Emca6 Estrogen-induced mammary cancer QTL 6 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 4:43,414,605...155,469,929 JBrowse link
Q Emca7 Estrogen-induced mammary cancer QTL 7 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 6:2,537,030...111,715,717 JBrowse link
Q Emca8 Estrogen-induced mammary cancer QTL 8 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 5:51,418,671...147,487,820 JBrowse link
Q Mamtr1 Mammary tumor resistance QTL 1 IDA RGD PMID:12844486 RGD:631852 NCBI chr 5:12,651,967...117,554,267 JBrowse link
Q Mamtr2 Mammary tumor resistance QTL 2 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:5,417,336...10,246,458 JBrowse link
Q Mamtr3 Mammary tumor resistance QTL 3 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:31,224,612...43,643,900 JBrowse link
Q Mamtr4 Mammary tumor resistance QTL 4 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:14,237,830...59,237,830 JBrowse link
Q Mamtr5 Mammary tumor resistance QTL 5 IDA RGD PMID:17230524 RGD:1599390 NCBI chr 5:18,847,913...63,847,913 JBrowse link
Q Mamtr6 Mammary tumor resistance QTL 6 IDA RGD PMID:17230524 RGD:1599390 NCBI chr18:20,285,758...87,080,053 JBrowse link
Q Mcs1 Mammary carcinoma susceptibility QTL 1 IDA RGD PMID:8168109 RGD:61080 NCBI chr 2:5,417,336...21,657,459 JBrowse link
Q Mcs12 Mammary carcinoma susceptibility QTL 12 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:60,225,095...61,370,302 JBrowse link
Q Mcs13 Mammary carcinoma susceptibility QTL 13 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:68,395,096...71,941,113 JBrowse link
Q Mcs14 Mammary carcinoma susceptibility QTL 14 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:78,777,540...83,269,259 JBrowse link
Q Mcs15 Mammary carcinoma susceptibility QTL 15 IDA RGD PMID:16568087 RGD:1581951 NCBI chr10:88,544,136...107,545,372 JBrowse link
Q Mcs16 Mammary carcinoma susceptibility QTL 16 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:1,868,045...43,724,576 JBrowse link
Q Mcs17 Mammary carcinoma susceptibility QTL 17 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:215,684,498...260,684,498 JBrowse link
Q Mcs18 Mammary carcinoma susceptibility QTL 18 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 2:5,417,336...42,777,046 JBrowse link
Q Mcs19 Mammary carcinoma susceptibility QTL 19 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 5:103,265,614...107,119,704 JBrowse link
Q Mcs2 Mammary carcinoma susceptibility QTL 2 IDA RGD PMID:9584103 RGD:61081 NCBI chr 7:24,738,680...40,433,335 JBrowse link
Q Mcs23 Mammary carcinoma susceptibility QTL 23 IDA RGD PMID:17404222 RGD:1601189
Q Mcs24 Mammary carcinoma susceptibility QTL 24 IDA RGD PMID:17404222 RGD:1601189 NCBI chr 5:68,838,385...113,838,385 JBrowse link
Q Mcs28 Mammary carcinoma susceptibility QTL 28 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:80,154,593...80,451,339 JBrowse link
Q Mcs29 Mammary carcinoma susceptibility QTL 29 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:80,229,223...80,401,274 JBrowse link
Q Mcs3 Mammary carcinoma susceptibility QTL 3 IDA RGD PMID:9584103 RGD:61081 NCBI chr 1:108,057,233...167,517,487 JBrowse link
Q Mcs30 Mammary carcinoma susceptibility QTL 30 IDA RGD PMID:24023717 RGD:7327193 NCBI chr12:1,258,139...10,257,059 JBrowse link
Q Mcs4 Mammary carcinoma susceptibility QTL 4 IDA RGD PMID:9584103 RGD:61081 NCBI chr 8:20,717,592...65,717,592 JBrowse link
Q Mcs5 Mammary carcinoma susceptibility QTL 5 IDA RGD PMID:11139513 RGD:62417 NCBI chr 5:56,991,667...137,729,065 JBrowse link
Q Mcs6 Mammary carcinoma susceptibility QTL 6 IDA RGD PMID:11139513 RGD:62417 NCBI chr 7:33,044,449...71,352,127 JBrowse link
Q Mcs7 Mammary carcinoma susceptibility QTL 7 IDA RGD PMID:11139513 RGD:62417 NCBI chr10:75,544,754...112,626,471 JBrowse link
Q Mcs8 Mammary carcinoma susceptibility QTL 8 IDA RGD PMID:11139513 RGD:62417 NCBI chr14:4,833,233...26,466,248 JBrowse link
Q Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 IDA RGD PMID:11139513 RGD:62417 NCBI chr 6:62,263,348...107,263,348 JBrowse link
number of squamous cell tumors of the tongue with diameter greater than 3 mm term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcas10 Tongue tumor susceptibility QTL 10 IDA RGD PMID:11429048 RGD:634723 NCBI chr10:33,179,030...78,179,030 JBrowse link
Q Tcas11 Tongue tumor susceptibility QTL 11 IDA RGD PMID:16527513 RGD:1578522 NCBI chr 5:47,745,646...167,946,134 JBrowse link
Q Tcas2 Tongue tumor susceptibility QTL 2 IDA RGD PMID:11429048 RGD:634723 NCBI chr 1:210,019,247...217,054,418 JBrowse link
Q Tcas3 Tongue tumor susceptibility QTL 3 IDA RGD PMID:11429048 RGD:634723 NCBI chr 4:7,342,404...92,484,039 JBrowse link
Q Tcas4 Tongue tumor susceptibility QTL 4 IDA RGD PMID:11429048 RGD:634723 NCBI chr14:19,191,541...43,957,628 JBrowse link
Q Tcas5 Tongue tumor susceptibility QTL 5 IDA RGD PMID:11429048 RGD:634723 NCBI chr19:5,007,571...43,907,843 JBrowse link
Q Tcas6 Tongue tumor susceptibility QTL 6 IDA RGD PMID:11429048 RGD:634723 NCBI chr 1:95,304,961...156,446,783 JBrowse link
Q Tcas8 Tongue tumor susceptibility QTL 8 IDA RGD PMID:11429048 RGD:634723
Q Tcas9 Tongue tumor susceptibility QTL 9 IDA RGD PMID:11429048 RGD:634723 NCBI chr 6:1...25,048,718 JBrowse link
number of squamous cell tumors of the tongue with diameter greater than 5 mm term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcat1 Tongue tumor resistance QTL 1 IDA RGD PMID:9563479 RGD:61091 NCBI chr 1:111,446,783...156,446,783 JBrowse link
pancreatic islet damage composite score term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Pancm1 Pancreatic morphology QTL 1 IDA RGD PMID:9169130 RGD:61083 NCBI chr 1:198,585,664...236,763,415 JBrowse link
percentage of study population developing cerebrovascular lesions during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Strs4 Sensitivity to stroke QTL 4 IDA RGD PMID:23690346 RGD:7411685 NCBI chr 1:79,689,548...124,689,548 JBrowse link
Q Strs5 Sensitivity to stroke QTL 5 IDA RGD PMID:23690346 RGD:7411685 NCBI chr18:51,609,032...67,502,266 JBrowse link
Q Strs6 Sensitivity to stroke QTL 6 IDA RGD PMID:23690346 RGD:7411685 NCBI chr 5:140,387,005...143,846,157 JBrowse link
Q Strs7 Sensitivity to stroke QTL 7 IDA RGD PMID:23690346 RGD:7411685 NCBI chr15:42,757,241...56,027,084 JBrowse link
percentage of study population developing mammary tumors during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca4 Estrogen-induced mammary cancer QTL 4 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 7:69,399,586...111,043,530 JBrowse link
Q Emca5 Estrogen-induced mammary cancer QTL 5 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 3:45,406,058...177,699,992 JBrowse link
percentage of study population developing T-cell lymphomas during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tls2 T-lymphoma susceptibility QTL 2 IDA RGD PMID:10360666 RGD:619600 NCBI chr 7:88,365,265...119,318,087 JBrowse link
Q Tls3 T-lymphoma susceptibility QTL 3 IDA RGD PMID:10360666 RGD:619600 NCBI chr10:53,625,815...98,939,209 JBrowse link
percentage of study population developing testis tumors during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tescar1 Testicular tumor resistance QTL 1 IDA RGD PMID:15805257 RGD:1358944 NCBI chr11:325,031...69,342,559 JBrowse link
percentage of study population developing trigeminal nerve neurilemmomas during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Schws1 Schwannoma susceptibility QTL 1 IDA RGD PMID:16003739 RGD:1559300 NCBI chr10:41,260,363...106,105,607 JBrowse link
Q Schws2 Schwannoma susceptibility QTL 2 IDA RGD PMID:16003739 RGD:1559300
Q Schws3 Schwannoma susceptibility QTL 3 IDA RGD PMID:16003739 RGD:1559300 NCBI chr 3:125,848,628...170,848,628 JBrowse link
Q Schws4 Schwannoma susceptibility QTL 4 IDA RGD PMID:16003739 RGD:1559300 NCBI chr 6:87,418,448...111,129,520 JBrowse link
Q Schws7 Schwannoma susceptibility QTL 7 IDA RGD PMID:16003739 RGD:1559300 NCBI chr10:4,835,638...20,170,031 JBrowse link
Q Schws8 Schwannoma susceptibility QTL 8 IDA RGD PMID:25303613 RGD:11566050 NCBI chr 6:99,273,921...144,273,921 JBrowse link
Q Schws9 Schwannoma susceptibility QTL 9 IDA RGD PMID:25303613 RGD:11566050 NCBI chr 6:66,129,520...111,129,520 JBrowse link
percentage of study population developing ventral prostate tumorous lesions during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Prcs1 Prostate cancer susceptibility QTL 1 IDA RGD PMID:15805257 RGD:1358944 NCBI chr19:15,939,528...38,798,459 JBrowse link
Q Prcs2 Prostate cancer susceptibility QTL 2 IDA RGD PMID:15805257 RGD:1358944 NCBI chr20:4,039,113...18,872,273 JBrowse link
post-insult time to mammary tumor formation term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca1 Estrogen-induced mammary cancer QTL 1 IDA RGD PMID:15611180 RGD:1358124 NCBI chr 5:102,945,579...154,732,228 JBrowse link
Q Emca10 Estrogen-induced mammary cancer QTL 10 IDA RGD PMID:18420736 RGD:2292503 NCBI chr 6:1,120,393...46,120,393 JBrowse link
Q Emca2 Estrogen-induced mammary cancer QTL 2 IDA RGD PMID:15611180 RGD:1358124 NCBI chr18:19,031,030...68,436,105 JBrowse link
Q Mcs26 Mammary carcinoma susceptibility QTL 26 IDA RGD PMID:20737482 RGD:4143380 NCBI chr 6:111,134,524...138,065,254 JBrowse link
Q Mcs27 Mammary carcinoma susceptibility QTL 27 IDA RGD PMID:20737482 RGD:4143380 NCBI chr13:48,776,655...53,264,877 JBrowse link
post-insult time to onset of cerebrovascular lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Strs1 Sensitivity to stroke QTL 1 IDA RGD PMID:8696337 RGD:61093 NCBI chr 1:133,946,489...178,946,489 JBrowse link
Q Strs2 Sensitivity to stroke QTL 2 IDA RGD PMID:8696337 RGD:61093 NCBI chr 5:142,309,061...173,707,219 JBrowse link
Q Strs3 Sensitivity to stroke QTL 3 IDA RGD PMID:8696337 RGD:61093 NCBI chr 4:39,208,222...84,208,222 JBrowse link
squamous cell carcinoma of the tongue maximum tumor diameter term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcas1 Tongue tumor susceptibility QTL 1 IDA RGD PMID:9563479 RGD:61091 NCBI chr19:1,957,707...46,957,707 JBrowse link
stomach tumor depth of invasion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Gcr3 Gastric cancer resistance QTL 3 IDA RGD PMID:10706129 RGD:69698 NCBI chr16:19,398,187...70,590,230 JBrowse link
stomach tumor diameter term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Gcr3 Gastric cancer resistance QTL 3 IDA RGD PMID:10706129 RGD:69698 NCBI chr16:19,398,187...70,590,230 JBrowse link
stomach tumor susceptibility score term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Gcr1 Gastric cancer resistance QTL 1 IDA RGD PMID:10706129 RGD:69698 NCBI chr 4:119,705,414...146,087,100 JBrowse link
Q Gcr2 Gastric cancer resistance QTL 2 IDA RGD PMID:10706129 RGD:69698 NCBI chr 3:3,285,929...28,136,884 JBrowse link
Q Gcs1 Gastric cancer susceptibility QTL1 IDA RGD PMID:10706129 RGD:69698 NCBI chr15:83,947,714...111,246,239 JBrowse link
volume of individual liver tumorous lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar1 Hepatocarcinoma resistance QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr10:6,229,289...36,185,929 JBrowse link
Q Hcar12 Hepatocarcinoma resistance QTL 12 IDA RGD PMID:12154055 RGD:629566 NCBI chr 3:30,114,912...123,700,444 JBrowse link
Q Hcar2 Hepatocarcinoma resistance QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 4:79,555,067...124,555,067 JBrowse link
Q Hcar3 Hepatocarcinoma resistance QTL 3 IDA RGD PMID:10493520 RGD:619598 NCBI chr 8:58,425,510...106,526,740 JBrowse link
Q Hcar9 Hepatocarcinoma resistance QTL 9 IDA RGD PMID:12154055 RGD:629566 NCBI chr 4:105,971,071...168,047,091 JBrowse link
Q Hcas4 Hepatocarcinoma susceptibility QTL 4 IDA RGD PMID:12154055 RGD:629566 NCBI chr16:5,013,802...50,169,318 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        brain lesion measurement + 8
        heart lesion measurement + 0
        kidney lesion measurement + 19
        liver lesion measurement + 29
        organ non-tumorous lesion measurement + 28
        organ tumorous lesion measurement + 108
        pancreas lesion measurement + 1
        prostate lesion measurement + 4
        stomach lesion measurement + 4
        testis lesion measurement + 1
        tongue lesion measurement + 11
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.